Early-onset cancers are increasing globally, with particularly notable rises in colorectal, pancreatic, uterine and liver cancers. Discussions at ASCO and AACR in 2026 highlighted growing concern that these trends represent a genuine epidemiological shift rather than improved detection alone.
Background
Historically, most cancers occurred in older adults. However, multiple studies now demonstrate increasing incidence in adults under 50. Researchers are investigating obesity, metabolic disease, dietary changes, microbiome alterations and environmental exposures as possible contributors.
Colorectal Cancer
Colorectal cancer represents one of the strongest examples of early-onset cancer. Incidence has increased steadily in younger adults across several countries and has become a leading cause of cancer death in younger age groups.
Pancreatic Cancer
Changes in diagnostic classification explain part of the observed increase, but do not fully account for rising incidence. Environmental and metabolic influences remain under investigation.
Environmental and Lifestyle Drivers
Potential contributors include obesity, ultra-processed foods, sedentary lifestyles, microbiome disruption, antibiotics, environmental chemicals and endocrine-disrupting compounds.
Birth-Cohort Effect
Evidence suggests that individuals born in more recent decades face higher risks than previous generations at the same age, implying long-term effects of early-life exposures.
Implications for Diagnostics
The increasing burden of early-onset cancer challenges traditional screening paradigms and may increase demand for scalable, accessible diagnostic technologies capable of supporting earlier detection and monitoring.
Frontier Perspective
The evolving epidemiology of cancer reinforces the importance of developing technologies that may support earlier biological insight. Future liquid biopsy approaches, including CTC and ctDNA analysis, may contribute to risk assessment and disease detection following appropriate clinical validation and regulatory approval.
Key Takeaways
• Early-onset cancers are increasing globally.
• Colorectal cancer provides some of the clearest evidence of a true epidemiological shift.
• Obesity alone does not explain observed trends.
• Microbiome and environmental factors are active areas of research.
• Birth-cohort effects suggest risks may persist into later life.
• Earlier and more personalised diagnostic approaches may become increasingly important.
Selected References
Ledford H. Why are so many young people getting cancer? What researchers do and don’t know. Nature. 2026.
Ugai T et al. Is early-onset cancer an emerging global epidemic? Nat Rev Clin Oncol. 2022.
AACR Cancer Research Catalyst. What’s Behind the Increase in Cancer Cases Among Younger Adults? 2026.
Sung H et al. Birth cohort patterns and cancer incidence in younger adults. Lancet Public Health. 2024.
